A destination center for immunotherapy in North Texas
When it comes to immunotherapy for cancer, few hospitals offer what we do—all in one convenient location. Baylor Scott & White Charles A. Sammons Cancer Center – Dallas represents one of the largest cancer treatment centers in Texas and offers comprehensive immunotherapy care in one place.
Our dedicated cancer hospital, outpatient cancer center, cancer urgent care, and onsite overnight accommodations free-of-charge at the American Cancer Society’s Hope Lodge—along with numerous support services—provide a single destination to care for you as a whole person.
We continue to research and advance numerous immunotherapies every day. This means you have access to clinical trials you won’t find elsewhere—and even more hope to destroy cancer.
Navigate your options
Our patient navigators help connect you with personalized cancer care, including advanced options like immunotherapy.
New tumor-infiltrating lymphocytes (TIL) cellular therapy treatment
Baylor University Medical Center is one of the first in the nation to offer a new tumor-infiltrating lymphocytes (TIL) cellular therapy treatment for patients with metastatic melanoma. This novel therapy is the first and only FDA-approved cellular treatment for a solid tumor—specifically metastatic melanoma—and offers hope for patients with advanced melanoma.
Fight cancer with your own immune cells
Cancer treatment has typically included three main approaches—chemotherapy, radiation and surgery. Now, immunotherapy gives you a fourth tool to defeat cancer.
Through cellular therapies in Dallas, we take your own immune cells, reprogram and multiply them in our lab, and infuse them back into your blood as new cancer-attacking cells. Other therapies use specific proteins or drugs to boost your immune system and help it fight cancer better.
Pioneering research and treatment in immunotherapies in Dallas, Baylor University Medical Center is one of the first North Texas providers to offer adult commercial use of chimeric antigen receptor T-cell therapy, or CAR-T, to treat patients with large B-cell lymphoma and acute lymphoblastic leukemia. We are also one of the first in the nation to offer FDA-approved tumor-infiltrating lymphocytes (TIL) cellular therapy for patients with metastatic melanoma.
Depending on your cancer, some immunotherapies include:
Texas Immuno-Oncology Biorepository (TIOB)
The Texas Immuno-Oncology Biorepository (TIOB) is a research facility that collects, catalogs and stores samples of biological material, such as urine, blood, stool, tissue, cells, DNA, RNA and protein, in an effort to improve our understanding of cancer.